#pharmaceutical industry

AIDS United’s working group of safety-net providers advances health equity—with help from the federal 340B Discount Drug Program.

The funding, which also supports harm reduction, arrives from the NY attorney general’s settlements with opioid manufacturers.

Do not fall for Gilead’s vile marketing ploy.

Stop me if you’ve heard this one before.

Among other issues: Out-of-pocket costs are increasingly passed on to consumers.

The FDA commissioner wants drugmakers to “end the shenanigans.”

For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.

He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.

U.S. lawmakers say appointing Azar is like putting “the pharmaceutical fox in charge of the health care henhouse.”

Amid the protests, funerals and endless meetings, these activists fight, love and dance.

Puerto Rico’s main exports are medical devices and pharmaceuticals, including HIV and cancer drugs.

Scott Gottlieb has said he wants lower costs and faster drug approvals.

But do Scott Gottlieb’s interests lie with drugmakers or patients?

He also told pharma leaders: “We have to get prices down. We have no choice.”

Deborah Waterhouse will lead the global HIV pharma company.

Report by HIV and hepatitis C advocates gives lawmakers and the White House a 100-day road map to tackling drug costs.